TARA

Protara Therapeutics, Inc. TARA

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TARA TCON RZLT XOMA VINC LRMR LYRA
6M 33.50 % 0.00 % 234.82 % 82.42 % -80.83 % 140.88 % 50.10 %
YTD -6.45 % 0.00 % 60.58 % 40.12 % -98.92 % 8.73 % -28.98 %
1Y 186.81 % -67.80 % 73.01 % 29.05 % -99.37 % -39.86 % -31.09 %
3Y 43.01 % -99.92 % 265.93 % 117.36 % -99.78 % 38.41 % -96.85 %
5Y -72.31 % -99.91 % -65.25 % 73.06 % -99.98 % -76.94 % -98.77 %
10Y -99.11 % -100.00 % -87.37 % 93.78 % -99.97 % -97.69 % -99.17 %
From the beginning -98.70 % -100.00 % -98.28 % -99.29 % -99.97 % -98.16 % -99.17 %

Dividend